-
- Andre Nel
- Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
-
- Tian Xia
- Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
-
- Lutz Mädler
- Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
-
- Ning Li
- Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
書誌事項
- 公開日
- 2006-02-03
- DOI
-
- 10.1126/science.1114397
- 公開者
- American Association for the Advancement of Science (AAAS)
この論文をさがす
説明
<jats:p>Nanomaterials are engineered structures with at least one dimension of 100 nanometers or less. These materials are increasingly being used for commercial purposes such as fillers, opacifiers, catalysts, semiconductors, cosmetics, microelectronics, and drug carriers. Materials in this size range may approach the length scale at which some specific physical or chemical interactions with their environment can occur. As a result, their properties differ substantially from those bulk materials of the same composition, allowing them to perform exceptional feats of conductivity, reactivity, and optical sensitivity. Possible undesirable results of these capabilities are harmful interactions with biological systems and the environment, with the potential to generate toxicity. The establishment of principles and test procedures to ensure safe manufacture and use of nanomaterials in the marketplace is urgently required and achievable.</jats:p>
収録刊行物
-
- Science
-
Science 311 (5761), 622-627, 2006-02-03
American Association for the Advancement of Science (AAAS)
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1363670319506886912
-
- NII論文ID
- 80019330700
-
- ISSN
- 10959203
- 00368075
-
- データソース種別
-
- Crossref
- CiNii Articles
